Not Just a Biomarker: YKL-40 Links Glial Clock to Amyloidosis
2020年12月22日 · Further, deleting the YKL-40 gene, Chi3l1, alters glial inflammatory responses, promotes astrocyte and microglial phagocytosis of Aβ, and mitigates amyloid plaque …
YKL-40 as a new promising prognostic marker of severity in COVID ...
2021年2月16日 · YKL-40 has a promitogenic action on pulmonary fibroblasts, increases the activity of macrophages and is associated with inflammatory disorders, arteriosclerosis and …
Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and ...
2020年12月22日 · Among the interesting findings is the fact that individuals who carry a genetic polymorphism resulting in lower CSF YKL-40 appear to have attenuated cognitive decline. …
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative ...
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017 Nov ...
YKL-40: a novel prognostic fluid biomarker for preclinical
2020年12月22日 · YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry. 2010 ...
Control vs Alzheimer's Disease: YKL-40 (Plasma and Serum)
YKL-40 is thought to be a marker of glial activation and inflammation. A handful of studies have now quantified YKL-40 in the blood of people with Alzheimer’s disease. Meta-analysis of four …
Alzheimer's Disease vs Control: YKL-40 (Plasma and Serum)
YKL-40 is thought to be a marker of glial activation and inflammation. Although all five comparisons show increased levels of YKL-40 in plasma in Alzheimer's patients compared …
Vascular Dementia vs Alzheimer's Disease: YKL-40 (CSF)
YKL-40 is thought to be a marker of glial activation and inflammation. Meta-analysis of three eligible studies showed slightly lower levels of YKL-40 in the cerebrospinal fluid of people with …
Alzheimer's Disease vs Control: YKL-40 (CSF) - ALZFORUM
YKL-40 is thought to be a marker of glial activation and inflammation. A number of studies have now quantified YKL-40 in the cerebrospinal fluid of people with Alzheimer’s disease. Meta …
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to ...
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort. Alzheimers Res Ther. 2015 Sep 17;7(1):59. …